ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,263 | -17.4% | 23,243 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $188,079 | +75.8% | 22,417 | -7.0% | 0.00% | 0.0% |
| Q1 2022 | $107,000 | +3.9% | 24,096 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $103,000 | -55.8% | 25,792 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $233,000 | -24.4% | 26,563 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $308,000 | +805.9% | 27,195 | +100.3% | 0.00% | – |
| Q1 2020 | $34,000 | -59.0% | 13,576 | -5.5% | 0.00% | – |
| Q4 2019 | $83,000 | +10.7% | 14,360 | +0.8% | 0.00% | – |
| Q3 2019 | $75,000 | -12.8% | 14,242 | -0.7% | 0.00% | – |
| Q2 2019 | $86,000 | -29.5% | 14,340 | +6.4% | 0.00% | – |
| Q1 2019 | $122,000 | +6.1% | 13,472 | -3.1% | 0.00% | – |
| Q4 2018 | $115,000 | -25.8% | 13,909 | +23.4% | 0.00% | -100.0% |
| Q3 2018 | $155,000 | +89.0% | 11,268 | +8.6% | 0.00% | – |
| Q2 2018 | $82,000 | – | 10,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |